CCAAT enhancer binding protein (C/EBP)
Stat3 and CCAAT/enhancer binding protein beta (C/EBP beta) regulate Jab1/CSN5 expression in mammary carcinoma cells
16
The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide
13
CCAAT/enhancer binding protein β promotes receptor activator of nuclear factor kappa B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
11
Biological roles of CCAAT/Enhancer-binding protein delta during inflammation
8
CCAAT/enhancer Binding Protein-alpha (C/EBP-alpha) is a DNA-damage Inducible p53-regulated Mediator of the G1 Checkpoint.
157
CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation
11
CCAAT/enhancer binding protein β is required for satellite cell self-renewal
11
Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation
19
Alterations of adiponectin gene expression and DNA methylation in adipose tissues and blood cells are associated with gestational diabetes and neonatal outcome
12
Low-dose monobutyl phthalate stimulates steroidogenesis through steroidogenic acute regulatory protein regulated by SF-1, GATA-4 and C/EBP-beta in mouse Leydig tumor cells
10
Production of interleukin 1 receptor antagonist by human articular chondrocytes
8
British Journal of Medicine & Medical Research
31
Oval Cells: Potential Role in Liver Regeneration
8
Serum amyloid A – a review
27
Genomic effects of the vitamin D receptor: Potentially the link between vitamin D, immune cells, and multiple sclerosis
14
Transcription factors: Are they a real target for future therapeutic strategies?
22
Phyto-polyphenols as potential inhibitors of breast cancer metastasis
17
Endoplasmic reticulum stress and apoptosis
18
Molecular structure and transcriptional regulation of the gene for the platelet derived growth factor alpha receptor in cultured vascular smooth muscle cells
11
miR-431 inhibits adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting insulin receptor substance 2
7